Full Press Release Details
DUBLIN , May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that its senior management team will provide a company overview and business and financial updates at the following virtual investor conferences:
Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com . A replay of the webcast will be archived on the website for at least one week.
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) is a global biopharmaceutical company dedicated to developing life-changing medicines for people with serious diseases — often with limited or no options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is in neuroscience, including sleep medicine and movement disorders, and in oncology, including hematologic malignancies and solid tumors. We actively explore new options for patients including novel compounds, small molecules, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
| Jazz Pharmaceuticals Contacts: | |
| Investors: Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations [email protected] Ireland +353 1 63 43211 | Media: Jacqueline Kirby Vice President, Corporate Affairs & Government Relations [email protected] Ireland +353 1 697 2141 U.S. +1 215 867 4910 |
SOURCE Jazz Pharmaceuticals plc